
Currently out of the existing stock ratings of Joshua Dennerlein, 32 are a SELL (19.88%), 62 are a HOLD (38.51%), 67 are a BUY (41.61%).
Analyst Joshua Dennerlein, currently employed at BAML, has had 65.94% of price targets met with an average potential upside of 25.84%, reached in 463 days on average.
Joshua Dennerlein has documented 304 price targets and ratings displayed on 36 stocks. The coverage is on Industrials, Financial Services sectors.
Most recent stock forecast was given on CTAS, Cintas at 15-Jul-2026.
Analyst best performing recommendations are on AHR (AMERICAN HEALTHCARE REIT).
The best stock recommendation documented was for AHR (AMERICAN HEALTHCARE REIT) on 8/8/2024. The price target of $19 was fulfilled within 14 days with a profit of $3.19 (20.18%), with a performance score of 14.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Mar-2026
$19
$3.1 (19.50%)
$15
6 days ago
(12-Nov-2026)
2/4 (50%)
$3.1 (19.50%)
30
Buy Since 20-Sep-2026
$19
$3.1 (19.50%)
$18
13 days ago
(05-Nov-2026)
4/15 (26.67%)
$2.99 (18.68%)
69
Hold Since 13-Oct-2025
$14
$-1.9 (-11.95%)
$16
30 days ago
(19-Oct-2026)
4/5 (80%)
$-0.1 (-0.71%)
103
Hold Since 04-Sep-2025
$16
$0.1 (0.63%)
$16
1 months 17 days ago
(01-Oct-2026)
7/14 (50%)
$2.03 (14.53%)
138
Sell Since 13-Nov-2025
$16
$0.1 (0.63%)
$14
1 months 26 days ago
(23-Sep-2026)
5/11 (45.45%)
$1.87 (13.23%)
123
Which stock is Joshua Dennerlein most bullish on?
What Year was the first public recommendation made by Joshua Dennerlein?